⌘K
Loading ticker…
As of 2026-08-24, Cognition Therapeutics, Inc. Common Stock (CGTX) has a 3-month relative strength percentile of 19 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 40. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.3%, relative volume 0.44×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
CGTX is in a stage 4 downtrend, week 3. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -8.1% / -19.3%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
CGTX appears in 1 ETF as of Apr 2026: IBRN at 0.11% weight, $5K notional.
Held by 3 ETFs · $2M across latest filings · largest weight 0.11% (IBRN).
Top 1 by value, from SEC N-PORT-P filings dated Apr 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| IBRN | 0.11% | $5K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CGTX Jan avg: 0.09% median: -1.55% win: 50% σ: 17.65% n: 4 2022-04-12 → 2026-07-31 | CGTX Feb avg: -16.17% median: -13.80% win: 0% σ: 15.91% n: 4 2022-04-12 → 2026-07-31 | CGTX Mar avg: -6.54% median: -9.79% win: 25% σ: 22.47% n: 4 2022-04-12 → 2026-07-31 | CGTX Apr avg: 9.86% median: 1.45% win: 60% σ: 32.22% n: 5 2022-04-12 → 2026-07-31 | CGTX May avg: -7.70% median: -5.42% win: 40% σ: 22.05% n: 5 2022-04-12 → 2026-07-31 | CGTX Jun avg: -3.60% median: -10.73% win: 20% σ: 19.59% n: 5 2022-04-12 → 2026-07-31 | CGTX Jul avg: 1.39% median: -10.43% win: 20% σ: 50.54% n: 5 2022-04-12 → 2026-07-31 | CGTX Aug avg: 71.95% median: 0.92% win: 50% σ: 162.64% n: 4 2022-04-12 → 2026-07-31 (current) | CGTX Sep avg: -23.25% median: -20.72% win: 0% σ: 18.99% n: 4 2022-04-12 → 2026-07-31 | CGTX Oct avg: 1.20% median: -2.78% win: 50% σ: 23.03% n: 4 2022-04-12 → 2026-07-31 | CGTX Nov avg: 19.66% median: -1.84% win: 25% σ: 52.05% n: 4 2022-04-12 → 2026-07-31 | CGTX Dec avg: 19.63% median: 22.13% win: 50% σ: 59.34% n: 4 2022-04-12 → 2026-07-31 |